Meeder Asset Management’s VolitionRx Ltd VNRX Stock Holding History

Meeder Asset Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29	Closed	-$2K	–	2677
2021 Q1	$2K	Buy	+29	New	+$2.49K	﹤0.01%	2123

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's VNRX Position: Q2 2021 in Review

Meeder Asset Management sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 29 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in VNRX in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

Meeder Asset Management reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
Meeder Asset Management sold 29 VolitionRx Ltd shares in Q2 2021, an estimated $2K.
Meeder Asset Management first reported a position in VolitionRx Ltd in Q1 2021 and held it in 1 quarter.
Meeder Asset Management's VolitionRx Ltd position peaked at $2K in Q1 2021.
46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Meeder Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.